冠心病左主干病变体外循环并行心脏不停跳冠状动脉搭桥术32例临床分析  

Clinical efficacy of on-pump beating-heart CABG in 32 cases of moderate to high-risk patients with coronary heart disease

作　　者：刘志平[1] 王坚[1] 李淑珍[1] 张玉龙[1] 赵龙[1] 郭俊晓[1] 任杰[1] 李育敏[1] 高荣[1] 赵文辉[2] LIU Zhi-ping , WANG Jian, LI Shu-zhen, et al.(Department of Cardiothoracic Surgery, Affiliated Hospital, Inner Mongolia, Medical College, Hohhot 010050, Chin)

机构地区：[1]内蒙古医科大学附属医院心脏大血管外科,内蒙古自治区呼和浩特市010050 [2]内蒙古医科大学附属医院检验科,内蒙古自治区呼和浩特市010050

出　　处：《中国心血管病研究》2018年第3期263-265,共3页Chinese Journal of Cardiovascular Research

摘　　要：目的分析并行体外循环下冠状动脉搭桥术对中高危冠心病患者的治疗效果。方法回顾分析从2013年1月至2017年8月采用并行体外循环心脏不停跳冠状动脉搭桥术治疗左主干病变32例患者的临床资料。结果所有患者靶血管均做到完全再血管化。全组无死亡，未使用主动脉内球囊反搏（IABP），无不良心血管事件发生。结论并行体外循环冠状动脉旁路移植术可以缩短中高危冠心病患者体外循环时间，减少术后监护和住院时间，减少患者住院费用。对不适于采用非体外循环冠状动脉旁路移植术治疗的中高危患者，建议优先考虑并行体外循环下冠状动脉旁路移植术。Objective To study the curative effect of on-pump beating heart CABG in moderate to high- risk patients with coronary heart disease （CHD）. Methods Review and analyze 32 cases of patients with clinical efficacy of on-pump beating-heart CABG in moderate to high-risk patients with coronary heart disease between January 2013 to August 2017. Results All the patients were completely target vessel revascularization, there was no death. Without the use of intra aortic balloon counterpulsation （IABP）, no adverse cardiovascular events. Conclusion The on-pump beating heart CABG could reduce the time of extracorporeal circulation, postoperative ICU stay time and the total cost. The moderate to high-risk patients who can not receive the OPCABG should give priority to the on-pump beating heart CABG.

关 键 词：冠状动脉疾病 并行体外循环冠状动脉旁路移植术 

分 类 号：R654.2[医药卫生—外科学]